• Mycetoma Research Center
    Mycetoma Research Center

    The Mycetoma Research Centre (MRC), University of Khartoum

    Read more
  • MRC Staff
    MRC Staff

    The staff members are of medical, health and science backgrounds who are interested in all facets related to mycetoma.

    MRC Staff:

    The staff members are of medical, health and science backgrounds who are interested in all facets related to mycetoma. They have rich track records in patients’ management, teaching, research and community development. The centre staff has continually explored new patients’ management approaches through clinical and basic research.

    Read more
  • A simple thorn prick
    A simple thorn prick

    Mycetoma : The faces of neglect

    How can a simple thorn prick be so devastating?

     

    Read more
  • Community Development
    Community Development
  • Mycetoma Management: A New Unique Holistic Approach
    Mycetoma Management: A New Unique Holistic Approach

 

The Drugs for Neglected Diseases Initiative Is the Anti Martin Shkreli:

For the Global Health Untold Stories Contest of 2015, we and colleagues at the Consortium of Universities for Global Health received 170 nominations of diseases and issues that impact global health but receive little or no attention from the mainstream media.

Sennar 930

 

Mycetoma had landed safely at the Neglected Tropical Diseases of the WHO, Geneva after a long and challenging journey.

The journal was planned, orchestrated and executed by devoted great and giants figures from The Sudan, The Netherland, United Kingdom, Mexico and Switzerland as well as prestigious organisations to mention but a few WHO-Sudan, DNDi,

 

AmyMaxmen HeadShotFeb2013

Amy Maxmen
Amy Maxmen [www.amymaxmen.com] is an award-winning science writer who covers the entanglements of medicine, policy, nature and of people behind research. Her stories appear in a variety of outlets, including Wired, National Geographic, Nature, and the New York Times. From Sudan and the Democratic Republic of Congo, she's reported two series for Global Health NOW on the most neglected diseases. Her feature in Nautilus magazine on the origin of humanity is anthologized in The Best American Science and Nature Writing 2015. Prior to writing, she earned a PhD from Harvard University in evolutionary biology. Twitter: @amymaxmen Instagram: @amaxmen

 

 

The First Clinical Trial in Mycetoma

Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to Test Drug Candidate for Eumycetoma Patients suffering from virtually no R&D for this neglected disease.

[Basel, Switzerland, Tokyo, Japan- 10 September 2015] The Drugs for Neglected Diseases initiative (DNDi) and the Japanese pharmaceutical company Eisai Co., Ltd. have signed an agreement to proceed with the clinical development of Eisai’santi-fungal drug fosravuconazole for the potential new treatment of eumycetoma, a fungal form of mycetoma, one of the world’s most neglected diseases.
Most probably transmitted through pricks to the skin by walking barefoot, eumycetoma is a chronic condition that affects people in tropical and subtropical regions, in particular across Africa, with the highest burden found in Sudan. The fungus penetrates the skin and causes massive tumour-like